Influence of mechanical and thermal energy on rifampicin

Sundani N. Soewandhi, Kosasih ., Rachmat Mauludin, Irvan Khaeruddin


The same raw material has opportunity to show different physical properties if it is produced by different industries. For such reason, rifampicin was chosen as a raw materials model, thats obtaining from five resource countries and were obtained from five different suppliers, each coded A, B, C, D and E. Each raw material was handled under tribomechanic and thermal treatment. Mechanical treatment was carried out by using grinding mill at 100 rpm for 30 minutes. Thermal treatment was carried out by oven at 105oC for 2 hours. Transformation occured, was identified by differential scanning calorymetry (DSC), X-ray powder diffraction and dissolution rate. The intrinsic dissolution rate was determined in 900 mL HCl 0,1N oxygen free, using basket and calculated through simultaneously determination method using uv spectrophotometry at λabs.maks. 475 nm. Thermograms of five milled raw material showed endothermic curve at 58oC without obviously melting curve.

Thermogram of heated raw material did not show endothermic curve except its melting at 188oC-192oC. Crystallinity indices of the raw materials decreased from C, E, B, A to D. The milled raw materials were mixture of rifampicin II (2%) and amorphous (98%). A and D were mixture of rifampicin form II and fines (amorph). The other samples were only rifampicin form II. All of the raw materials showed different dissolution rates. Rifampicin B,C and D had sameness dissolution rate, whether milled or heated.

Key words: Rifampicin II, rifampicin amorphous, DSC, powder X-ray diffraction, dissolution rate

Full Text:



Afianti S., 2004, Identifikasi perubahan fisika rifampisin akibat pemberian energi mekanik secara kristalografi, Departemen Farmasi FMIPA ITB.

Ditjen POM, 1995, Departemen Kesehatan Republik Indonesia, Farmakope Indonesia, edisi IV, Indonesia, 744-746.

Florey, K., 1976, Analytical Profiles of Drugs Substances, volume V, Academic Press, New York, San Francisco, London, 470 – 505.

Giron, D., 2001, Investigations of polymorphism and pseudo-polymorphism in pharmaceuticals by combined thermoanalytical techniques, Journal of Thermal Analysis and Calorimetry, 64, 37-60.

Henwood, S.Q., M. M. De Villeiers, W. Liebenberg, A.P. Lötter, 2000, Solubility and dissolution properties of generic rifampicin raw material, Drug Development and Industrial Pharmacy, Vol 26 No.4, 403-408.

Henwood, S.Q., M. M. De Villeiers, W. Liebenberg, A.P. Lötter, & L.R. Tied, 2001, Characterization of the solubility and dissolution properties of several new Rifampicin polymorphs, solvates and hydrate, Drug Dev. and Ind. Pharm. Vol 27 No.10, 1017- 1030.

Irvan K., 2003, Teknik pemilihan bahan baku Rifampisin melalui metode kristalografi, Departemen Farmasi FMIPA ITB.

Mutschler E., 1996, Arzneimittelwirkungen, 7 neu bearbeitete Auflage, Wissenschaftliche Verlagsgeselschaft mbH Stuttgart, 702-703.

Pelizza, G., Nebuloni, M., Ferrari, P., and Gallo, G.G., 1977, Polymorphism of Rifampicin, Il Farmaco Ed., 32, 471-481.



  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats